26.
S.Amdt.2132 — 112th Congress (2011-2012)Purpose:
To provide that a portion of the performance awards of each employee of the Center for Drug Evaluation and Research, the Center for Devices and Radiological Health, and the Center for Biologics Evaluation and Research be connected to an evaluation of the employee's contribution to goals under the user fee agreements. Sponsor:Sen. Coburn, Tom [R-OK] (Submitted 05/22/2012) (Proposed 05/23/2012)
Latest Action: 05/24/12 Proposed amendment SA 2132 withdrawn in Senate. (consideration: CR S3547) (All Actions)

26.
S.Amdt.2132 — 112th Congress (2011-2012)Purpose:To provide that a portion of the performance awards of each employee of the Center for Drug Evaluation and Research, the Center for Devices and Radiological Health, and the Center for Biologics Evaluation and Research be connected to an evaluation of the employee's contribution to goals under the user fee agreements.Sponsor:Sen. Coburn, Tom [R-OK] (Submitted 05/22/2012) (Proposed 05/23/2012)Latest Action:05/24/12 Proposed amendment SA 2132 withdrawn in Senate. (consideration: CR S3547) (All Actions)

43.
S.Amdt.2111 — 112th Congress (2011-2012)Purpose:
To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive "pay-for-delay" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market. Sponsor:Sen. Bingaman, Jeff [D-NM] (Submitted 05/17/2012) (Proposed 05/24/2012)
Latest Action: 05/24/12 Amendment SA 2111, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 28 - 67. Record Vote Number: 105. (All Actions)

43.
S.Amdt.2111 — 112th Congress (2011-2012)Purpose:To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive "pay-for-delay" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market.Sponsor:Sen. Bingaman, Jeff [D-NM] (Submitted 05/17/2012) (Proposed 05/24/2012)Latest Action:05/24/12 Amendment SA 2111, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 28 - 67. Record Vote Number: 105. (All Actions)

45.
S.Amdt.2109 — 112th Congress (2011-2012)Purpose:
To revoke the exclusivity of certain entities that are responsible for violations of the Federal Food, Drug, and Cosmetic Act, the False Claims Act, and other certain laws. Sponsor:Sen. Sanders, Bernard [I-VT] (Submitted 05/17/2012) (Proposed 05/23/2012)
Latest Action: 05/24/12 Amendment SA 2109, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 9 - 88. Record Vote Number: 109. (All Actions)

45.
S.Amdt.2109 — 112th Congress (2011-2012)Purpose:To revoke the exclusivity of certain entities that are responsible for violations of the Federal Food, Drug, and Cosmetic Act, the False Claims Act, and other certain laws.Sponsor:Sen. Sanders, Bernard [I-VT] (Submitted 05/17/2012) (Proposed 05/23/2012)Latest Action:05/24/12 Amendment SA 2109, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 9 - 88. Record Vote Number: 109. (All Actions)

46.
S.Amdt.2108 — 112th Congress (2011-2012)Purpose:
To prohibit approval by the Food and Drug Administration of genetically engineered fish unless the National Oceanic and Atmospheric Administration concurs with such approval. Sponsor:Sen. Murkowski, Lisa [R-AK] (Submitted 05/17/2012) (Proposed 05/23/2012)
Latest Action: 05/24/12 Amendment SA 2108, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 46 - 50. Record Vote Number: 106. (All Actions)

46.
S.Amdt.2108 — 112th Congress (2011-2012)Purpose:To prohibit approval by the Food and Drug Administration of genetically engineered fish unless the National Oceanic and Atmospheric Administration concurs with such approval.Sponsor:Sen. Murkowski, Lisa [R-AK] (Submitted 05/17/2012) (Proposed 05/23/2012)Latest Action:05/24/12 Amendment SA 2108, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 46 - 50. Record Vote Number: 106. (All Actions)

47.
S.Amdt.2107 — 112th Congress (2011-2012)Purpose:
To allow the importation by individuals of safe and affordable drugs from Canada. Sponsor:Sen. McCain, John [R-AZ] (Submitted 05/17/2012) (Proposed 05/24/2012)
Latest Action: 05/24/12 Amendment SA 2107, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 43 - 54. Record Vote Number: 108. (All Actions)

47.
S.Amdt.2107 — 112th Congress (2011-2012)Purpose:To allow the importation by individuals of safe and affordable drugs from Canada.Sponsor:Sen. McCain, John [R-AZ] (Submitted 05/17/2012) (Proposed 05/24/2012)Latest Action:05/24/12 Amendment SA 2107, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 43 - 54. Record Vote Number: 108. (All Actions)